Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kristen Marks, MD, MS
New York Presbyterian Hospital-Cornell
Principal Investigator - Marshall Glesby, MD, PhD
Cornell Clinical Trials Unit, Weill Medical College of Cornell University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Aids Crs (801)
San Francisco, California, United States
- Northwestern University Crs (2701)
Chicago, Illinois, United States
- New Jersey Medical School-Adult Clinical Research Ctr. Crs (31477)
Newark, New Jersey, United States
- Cornell Crs (7804)
New York, New York, United States
- Ny Univ. Hiv/aids Crs (401)
New York, New York, United States
- Aids Care Crs (1108)
Rochester, New York, United States
- Metro Health Crs (2503)
Cleveland, Ohio, United States
- Virginia Commonwealth Univ. Medical Ctr. Crs (31475)
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 May 2011
- Completion
- 31 Dec 2011
- Last update posted
- 12 Oct 2018
- Registered enrollment
- 19
- Registry id
- NCT00665353
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.